Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ingredion (INGR) Other Accumulated Expenses (2016 - 2026)

Ingredion filings provide 16 years of Other Accumulated Expenses readings, the most recent being $575.0 million for Q4 2025.

  • On a quarterly basis, Other Accumulated Expenses fell 9.16% to $575.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $575.0 million, a 9.16% decrease, with the full-year FY2025 number at $575.0 million, down 9.16% from a year prior.
  • Other Accumulated Expenses hit $575.0 million in Q4 2025 for Ingredion, up from $569.0 million in the prior quarter.
  • In the past five years, Other Accumulated Expenses ranged from a high of $633.0 million in Q4 2024 to a low of $44.0 million in Q4 2021.
  • Median Other Accumulated Expenses over the past 5 years was $546.0 million (2023), compared with a mean of $494.6 million.
  • Biggest five-year swings in Other Accumulated Expenses: plummeted 77.08% in 2021 and later skyrocketed 959.09% in 2022.
  • Ingredion's Other Accumulated Expenses stood at $44.0 million in 2021, then skyrocketed by 959.09% to $466.0 million in 2022, then rose by 17.17% to $546.0 million in 2023, then increased by 15.93% to $633.0 million in 2024, then dropped by 9.16% to $575.0 million in 2025.
  • The last three reported values for Other Accumulated Expenses were $575.0 million (Q4 2025), $569.0 million (Q3 2025), and $552.0 million (Q2 2025) per Business Quant data.